How do changes in motivation to prevent pregnancy influence contraceptive continuation? Results from a longitudinal study with women who receive family planning services from Community Pharmacists and Patent and Proprietary Medicine Vendors in Nigeria (doi:10.7910/DVN/TINIGW)

View:

Part 1: Document Description
Part 2: Study Description
Part 3: Data Files Description
Part 5: Other Study-Related Materials
Entire Codebook

How do changes in motivation to prevent pregnancy influence contraceptive continuation? Results from a longitudinal study with women who receive family planning services from Community Pharmacists and Patent and Proprietary Medicine Vendors in Nigeria

doi:10.7910/DVN/TINIGW

Harvard Dataverse

2022-03-22

1

Dwyer, Sara Chace; Baruwa, Sikiru; Okafor, Emeka; Oluseyi, Daini Babajide; Ubuane, Osimhen I.; Jain, Aparna, 2022, "How do changes in motivation to prevent pregnancy influence contraceptive continuation? Results from a longitudinal study with women who receive family planning services from Community Pharmacists and Patent and Proprietary Medicine Vendors in Nigeria", https://doi.org/10.7910/DVN/TINIGW, Harvard Dataverse, V1, UNF:6:0IdBMmTj6ivqyvQWdrXsSA== [fileUNF]

How do changes in motivation to prevent pregnancy influence contraceptive continuation? Results from a longitudinal study with women who receive family planning services from Community Pharmacists and Patent and Proprietary Medicine Vendors in Nigeria

doi:10.7910/DVN/TINIGW

Dwyer, Sara Chace (Population Council)

Baruwa, Sikiru (Population Council)

Okafor, Emeka (Society for Family Health)

Oluseyi, Daini Babajide (Population Council)

Ubuane, Osimhen I. (Population Council)

Jain, Aparna (Population Council)

Harvard Dataverse

Ubuane, Osimhen I.

Ubuane, Osimhen

2022-03-21

https://doi.org/10.7910/DVN/TINIGW

Social Sciences, Social Sciences, Family planning, Pregnancy motivation, Drug shops, Pharmacies, Task sharing, Private sector

<p>The IntegratE project is a proof-of-concept that Community Pharmacists (CPs) and Patent and Proprietary Medicine Vendors (PPMVs) have the capacity to provide a wider range of family planning (FP) and primary health care (PHC) services than they are currently authorized by law to provide. The project seeks to improve the quality of FP and PHC services provided by CPs and PPMVs and support the creation of an enabling environment that will sustain these services.</P> <p>The dataset includes data from a larger evaluation of the IntegratE project which seeks to expand access to family planning (FP) in Nigeria through community pharmacies and drug shops. 491 women were interviewed within 10 days after receiving a FP service (counseling, referral or FP method) from these sources and again nine months later. We then used logistic regression models to assess whether changes in motivation to avoid pregnancy between receiving a FP service to 9 months later is associated with continued use of FP.</P> <p>We found that many women (89%) continued using contraception approximately 9 months after the enrollment interview. Women who remained highly motivated (reported it was very important to avoid pregnancy at both interviews) were more likely to continue using contraception compared to women who became more motivated between the two interviews. Women who became less motivated were 65% less likely to continue using contraception compared to who became more motivated. Our results suggest that FP providers, including private sector pharmacists and drug shop owners, should continuously check in with women about their motivations around pregnancy to support continuation contraceptive use among those who wish to avoid pregnancy.</P>

2019-06-2020-07

Nigeria, Nigeria

Kaduna, Lagos

Individual

Quantitative

Questionnaire

CC0 Waiver

<p>Data request is required to access the data from this study: <a href="https://pcouncil.wufoo.com/forms/population-council-application-for-data-use/">Application for Data Use</a></p> <p>CONFIDENTIALITY: You will not attempt to identify individual study participants. You will not report information that could directly or by inference identify individual study participants. ETHICS: You will obtain relevant IRB approval prior to using the data. ACCESS: Access to the data will be limited to the persons requesting data. You will not distribute nor permit others to distribute any of the data to a person who is not listed. SECURITY: You will store and analyze data in a secure computing environment. ACKNOWLEDGMENT: You will cite the dataset as the source in all reports, presentations, and publications based on the data. Citations will appear in footnotes or in the reference section of any manuscripts. See suggested citation. You will cite the funding source. PUBLICATIONS: At the conclusion of the proposed research, you will provide a copy of any publication or report based in whole or in part on the data. LOSS OF PRIVILEGE TO USE DATA: If it is determined that you are in violation of these terms and conditions, you will destroy the data set, and any derivative data files, upon request.</p>

• Number of cases: 595

• No. of variables per record: 752

• Type of File: text/tab-separated-values

UNF:6:0IdBMmTj6ivqyvQWdrXsSA==

Label:

client exit interview_2019_4_16_.pdf

application/pdf

Label:

Client follow-up survey 2020 04 23.pdf

application/pdf

Label:

Fertility analysis paper_codebook.log

text/plain